Safety and Efficacy Study of Single Weekly Bortezomib in Newly Diagnosed Multiple Myeloma
Status:
Completed
Trial end date:
2015-03-01
Target enrollment:
Participant gender:
Summary
This is a research study to see if a new drug called bortezomib is useful to treat multiple
myeloma in people who are newly diagnosed, and have not yet received treatment for their
disease. VELCADE® (bortezomib) for Injection is a drug under development by Millennium
Pharmaceuticals, Inc.